Company Profile
Xtant Medical Stock Price, News & Analysis
- Ticker:
- XTNT
- Exchange:
- AMEX
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.44 USD (+0.61%)
Close
Last updated: August 6, 2026
65.2M USD
Market cap
Why the stock is moving
The latest company update was “Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026”. XTNT changed 0.61% and closed at $0.4427 on Aug 6, 2026, indicating a relatively limited closing-price reaction to this earnings update.
Company overview
Orthopedic Surgical Products Company
Xtant Medical develops and distributes surgical products for spinal and other orthopedic procedures.
Biologics and Implants
The portfolio includes bone grafts, biologic materials, spinal fixation systems, and related surgical instruments.
Hemostasis Expansion
An exclusive U.S. distribution agreement for HEMOBLAST Bellows expands Xtant into flowable hemostatic products used to control surgical bleeding.
Commercial Distribution Model
Xtant combines internally owned products with licensed technologies distributed through a dedicated U.S. sales organization.
Future catalysts
Xtant Medical’s catalysts are orthopedic biologics, spine product execution, and any margin or portfolio update that improves the business mix. The market cares about steady adoption rather than a single headline.
Recent news
- 01
Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026
Source: Xtant Medical
- 02
Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference
Source: Xtant Medical
- 03
Xtant Medical Reports First Quarter 2026 Financial Results
Source: Xtant Medical
- 04
Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026
Source: Xtant Medical
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Xtant Medical (XTNT)?
Xtant Medical (XTNT) most recently closed at 0.44 USD, a +0.61% move versus the previous session.
What is the market cap of Xtant Medical (XTNT)?
Xtant Medical currently has a market capitalization of 65.2M USD on BioPharmSignal.
What does Xtant Medical do?
Orthopedic Surgical Products Company Xtant Medical develops and distributes surgical products for spinal and other orthopedic procedures. Biologics and Implants The portfolio includes bone grafts, biologic materials, spinal fixation systems, and related surgical instruments. Hemostasis Expansion An exclusive U.S. distribution agreement for HEMOBLAST Bellows...
On which exchange is XTNT stock listed?
Xtant Medical (XTNT) is associated with AMEX, United States, Biopharma.
What is Orthopedic?
Xtant Medical’s catalysts are orthopedic biologics, spine product execution, and any margin or portfolio update that improves the business mix.
Which conditions is Xtant Medical targeting with Orthopedic?
Xtant Medical’s catalysts are orthopedic biologics, spine product execution, and any margin or portfolio update that improves the business mix.
How does Xtant Medical describe recent progress with Orthopedic?
Xtant Medical’s catalysts are orthopedic biologics, spine product execution, and any margin or portfolio update that improves the business mix.
What is Surgical?
Orthopedic Surgical Products Company Xtant Medical develops and distributes surgical products for spinal and other orthopedic procedures.